Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Novo Nordisk Pharma S.A
Woman and Man Max 99 years
Novo Nordisk Pharma S.A
Update Il y a 5 ans
Ensayo multicéntrico, abierto, aleatorizado, de dos grupos, paralelo para comparar el cambio en la distribución de grasa en sujetos con sobrepeso y obesos con diabetes tipo 2 tras 26 semanas de tratamiento con insulina detemir una vez al día frente a insulina NPH una vez al día, ambas con insulina aspart a la hora de las comidas
To compare the change in trunk fat mass, assessed by DEXA, after 26 weeks of treatment with insulin detemir or insulin NPH (both with insulin aspart in the main meals) in overweight and obese type 2 d...
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Novo Nordisk Pharma S.A
Update Il y a 5 ans
A multi-centre, open-labelled, randomised, two-group parallel, treat-to-target trial comparing the weight change in overweight and obese subjects with type 2 diabetes after 26 weeks of treatment with insulin detemir once daily versus insulin NPH once daily, both with insulin aspart in the mealtime. (PREDICTIVE-BMI study)
To compare the weight change during 26 weeks of treatment with insulin detemir versus NPH insulin in obese or overweight type 2 diabetic subjects.
Country
None
organs
None
Specialty
None
unknown
More information